Eligibility: Available to patients with commercial prescription insurance coverage for TARKA who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the TARKA Savings Card and patient must call OPUS Health at 800.364.4767 to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the TARKA Savings Card from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance.

Terms and ConditionsPharmacist instructions:

Submit the copay card authorized for all commercially insured patients by the patient’s primary insurance as a secondary transaction to OPUS Health.

When you use this card, you are confirming that you have not submitted and will not submit a claim for this prescription for reimbursement under any federal, state, or government-funded healthcare program, such as Medicare (including Part D), Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs. Pharmacists with questions, please call OPUS Health at 800.364.4767.

TARKA® (trandolapril/verapamil hydrochloride ER tablets) Use and Important Safety Information1

USE for TARKA

TARKA is a prescription medicine used to treat high blood pressure.

TARKA combines two blood pressure medicines (trandolapril and verapamil) into one pill. TARKA is not to be used for initial treatment of high blood pressure.

IMPORTANT SAFETY INFORMATION for TARKA

TARKA should not be taken by women during pregnancy due to the risk of injury and even death to the developing fetus. If you become pregnant, tell your doctor right away and follow the instructions you receive about taking TARKA.

Do not take TARKA if you are a nursing mother.

Some patients taking TARKA may experience heart problems, including changes in heart rhythm. TARKA should not be taken by people with certain heart conditions or low blood pressure. If you are a diabetic patient, do not take TARKA if you are also taking aliskiren. It is very important that your doctor is aware of all current and past medical conditions, including heart problems, liver, or kidney disease.

Do not take TARKA if you are allergic to verapamil or an ACE inhibitor or if you are taking a medicine that is a neprilysin inhibitor (e.g., sacubitril). Do not take TARKA within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor. Ask your doctor about your medications for more information.

Tell your doctor about any allergic reactions to all medications. TARKA may cause serious allergic reactions or a reaction called angioedema which includes swelling of the face, body, lips, tongue, or throat. If this occurs, contact your doctor or seek emergency care right away.

TARKA may cause excessive low blood pressure and dizziness, especially in certain types of patients with heart failure or who are salt- or volume-depleted.

TARKA can cause liver problems. Notify your doctor immediately if you develop symptoms of jaundice, such as yellow coloring of the skin and eyes, while on TARKA.

If you have kidney disease or connective tissue disease, your doctor should do periodic blood tests, as TARKA may decrease your white blood cell count.

TARKA can interact with other medicines. Before and while taking TARKA, tell your doctor about all medications that you are taking, including prescription and nonprescription drugs.

This is the most important information you should know about TARKA. For more information, talk to your doctor.

Reference: 1. TARKA [package insert]. North Chicago, IL: AbbVie Inc.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088(1-800-332-1088).

If you cannot afford your medication, contact www.pparx.org for assistance.

If you have any questions about AbbVie's MyTARKA.com website that have not been answered, click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only, and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and take into consideration the unique characteristics of each patient.

TARKA® (trandolapril/verapamil hydrochloride ER tablets) Use and Important Safety Information1

USE for TARKA

TARKA is a prescription medicine used to treat high blood pressure.

TARKA combines two blood pressure medicines (trandolapril and verapamil) into one pill. TARKA is not to be used for initial treatment of high blood pressure.

IMPORTANT SAFETY INFORMATION for TARKA

You are leaving MyTARKA.com

You are leaving the AbbVie website and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site’s endorsement of MyTARKA.com or AbbVie.

You are leaving MyTARKA.com consumer site

You are about to enter a site that is for U.S. Healthcare Professionals only. By selecting "Yes" below, you certify that you are a Healthcare Professional and that you wish to proceed to the Healthcare Professionals Only section of this site. Products or treatments described on this site are available in the U.S. but may not be available in all other countries.

I am a licensed Healthcare Professional and wish to proceed to the Healthcare Professionals Only section of this site.